The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 46-51

Bentham Science Publishers

Access to resources Recommend Favorite

FAK and Nanog Cross Talk with p53 in Cancer Stem Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 4, 2013-05 ,pp. : 576-580

Bentham Science Publishers

Access to resources Recommend Favorite

Role of T antigen interactions with p53 in tumorigenesis

By Pipas J.M.   Levine A.J.  

Seminars in Cancer Biology, Vol. 11, Iss. 1, 2001-02 ,pp. : 23-30

Academic Press

Access to resources Recommend Favorite

A Novel Small Molecule Inhibitor of FAK and IGF-1R Protein Interactions Decreases Growth of Human Esophageal Carcinoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 7, 2011-09 ,pp. : 629-637

Bentham Science Publishers

Access to resources Recommend Favorite

Immunohistochemical Analysis of p53 Protein in Uterine Sarcomas

By Nordal R.R.   Kristensen G.B.   Stenwig A.E.   Trope C.G.   Nesland J.M.  

Gynecologic Oncology, Vol. 70, Iss. 1, 1998-07 ,pp. : 45-48

Elsevier

Access to resources Recommend Favorite